Locally advanced rectal cancer transcriptomic-based secretome analysis reveals novel biomarkers useful to identify patients according to neoadjuvant chemoradiotherapy response.

MLA

Canto, Luisa Matos do, et al. “Locally Advanced Rectal Cancer Transcriptomic-Based Secretome Analysis Reveals Novel Biomarkers Useful to Identify Patients According to Neoadjuvant Chemoradiotherapy Response.” Scientific Reports, vol. 9, no. 1, June 2019, p. 8702. EBSCOhost, https://doi.org/10.1038/s41598-019-45151-w.

APA

Canto, L. M. do, Cury, S. S., Barros-Filho, M. C., Kupper, B. E. C., Begnami, M. D. F. de S., Scapulatempo-Neto, C., Carvalho, R. F., Marchi, F. A., Olsen, D. A., Madsen, J. S., Havelund, B. M., Aguiar, S., Jr, & Rogatto, S. R. (2019). Locally advanced rectal cancer transcriptomic-based secretome analysis reveals novel biomarkers useful to identify patients according to neoadjuvant chemoradiotherapy response. Scientific Reports, 9(1), 8702. https://doi.org/10.1038/s41598-019-45151-w

Chicago

Canto, Luisa Matos do, Sarah Santiloni Cury, Mateus Camargo Barros-Filho, Bruna Elisa Catin Kupper, Maria Dirlei Ferreira de Souza Begnami, Cristovam Scapulatempo-Neto, Robson Francisco Carvalho, et al. 2019. “Locally Advanced Rectal Cancer Transcriptomic-Based Secretome Analysis Reveals Novel Biomarkers Useful to Identify Patients According to Neoadjuvant Chemoradiotherapy Response.” Scientific Reports 9 (1): 8702. doi:10.1038/s41598-019-45151-w.